Patent · US Active

Parathyroid hormone receptor 1 (PTH1R) antibodies and uses thereof

US11787876B2 · kind B2 · utility

0Cited by

38References

24Claims

0Family size

Assignee

XOMA (US) LLC · US

Inventors

Raphael D. Levy · Berkeley, US
Hassan Issafras · Berkeley, US
Agnes Choppin Holmes · Mountain View, US
Kirk W. Johnson · Berkeley, US
Amer M. Mirza · San Francisco, US
Daniel Bedinger · Vacaville, US
Rachel A. Hunt · Berkeley, US
Toshihiko Takeuchi · Oakland, US
Kiranjit Kaur Ahluwalia · Fremont, US
Robyn Cotter · Oakland, US

Key dates

Filing date	Nov 26, 2019
Grant date	Oct 17, 2023
Priority date	—
Expiry date	Nov 26, 2039

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/635
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates, in general, human antibodies against human parathyroid hormone receptor 1 (PTH1R) and methods of use of such antibodies in the treatment of cancer, Humoral Hypercalcemia of Malignancy (HHM), or Primary Hyperparathyroidism (PHPT) and Secondary Hyperparathyroidism (SHPT) and cachexia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.